Hemophilia is a rare inherited bleeding disorder where the blood fails to clot normally due to a lack of blood clotting proteins known as clotting factors. The condition leads to spontaneous bleeding ...

Hemophilia A, also known as classic hemophilia or factor VIII deficiency, is a bleeding disorder. It occurs when certain proteins are missing in the blood, causing people to bleed and bruise easily.

Study authors determined that regular musculoskeletal assessments can help facilitate personalized care for patients who have hemophilia, in that they can detect changes early. Functional ability ...

Hemophilia A and B are similar conditions that affect the blood’s ability to clot. They typically occur due to gene variations that affect different blood clotting factors. Hemophilia is a group of ...

Please provide your email address to receive an email when new articles are posted on . As a disease that traditionally has been thought to only affect men, hemophilia has acquired the false ...

Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients so far. What’s the holdup?

Hemophilia B is a severe X-linked bleeding diathesis caused by the absence of functional blood coagulation factor IX, and is an excellent candidate for treatment of a genetic disease by gene therapy.